Northwestern Medicine scientists have identified a guardian molecule triggered by testosterone that appears to protect males from multiple sclerosis.
Northwestern Medicine scientists have discovered a protein that acts as an entry point for the Epstein-Barr virus, providing a potential target for future therapies.
A newly-designed mutant herpes virus provides a strategy for the development of novel herpes virus vaccines.
A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.
A new study has demonstrated how a specific class of immune cells represent a previously unknown link between high cholesterol and the development of symptoms characteristic of psoriasis.
An international team of scientists, led by Northwestern, has determined the 3-D atomic structure of more than 1,000 proteins that are potential drug and vaccine targets.
A Northwestern Medicine study, led by a fifth-year PhD student, has demonstrated that a cytokine known to be important in allergic disease called interleukin-33 (IL-33) plays a key role regulating stem cells under normal, healthy conditions.
Recent research published in Nature Communications examined genetic variation in North and South American, Caribbean and West African populations in light of the African Diaspora.
Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.
A biodegradable nanoparticle can hide an allergen in a friendly shell to convince the immune system not to attack it, according to new Northwestern Medicine research.